We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves First Generic for Treating Severe Hypoglycemia
FDA Approves First Generic for Treating Severe Hypoglycemia
The FDA has given the green light for the first generic version of glucagon for injection, a drug that’s long been approved for treating severe hypoglycemia (very low blood sugar) that may occur in diabetes patients.